Travelphage TM Annotation


Travelphage TM

Trade name: TRAVELPHAGE TM

Description: Hard gelatin capsule of blue cap and body.

Composition:  

1 capsule contains:

As an active substance: Sterile phagolisates concentrate on the following lyophilized bacterias: Shigella, Salmonella, E.Coli, Proteus, Staphylococcus, Pseudomonas, Enterococcus.

Strength:

The titer of each phage:

Bacteriophagum Shigella;

Bacteriophagum Salmonella;

Bacteriophagum E.coli;

Bacteriophagum Proteus;

Bacteriophagum Staphylococcus;

Bacteriophagum Pseudomonas;

Bacteriophagum Enterococcus

Is not less than – 105.

Pharmaceutical form: Capsule for oral use.

Pharmacotherapeutic group: Specific antibacterial agent

Pharmacological activity: The bacteriophage is a specific virus against target bacteria, which is absorbed into the cell membrane of homological bacteria, destroys its hostility, penetrates into bacteria’s cell, propagates, and causes the lysis of it.

TRAVELPHAGE TM contains only selected virulent phages, against specific bacterias: Shigella, Salmonella, E. Coli, Proteus, Staphylococcus, Pseudomonas, Enterococcus. That is conditioning the high activity and efficacy of this product.

Absorption: with oral administration, the active constituents of medicine are rapidly absorbed into blood and lymph from the gastrointestinal system and easily reach the nidus of infection.

Excretion: the medicine is mainly excreted by kidneys and also by the gastrointestinal tract.

Therapeutic indications: Travelphage is indicated for the treatment and prophylaxis of the diseases caused by following bacterias: Shigella, Salmonella, E.Coli, Proteus, Staphylococcus, Pseudomonas, Enterococcus or by diseases caused of their unity, like shigellosis, typhoid, paratyphoid, dysbacteriosis, enterocolitis, acute and chronic colitis, dyspepsia in complex therapy, foodborne infections and other bacterial diarrheas.

For prophylaxis, TRAVELPHAGE TM is also prescribed in patients of high-risk groups for their epidemiological safety.

Contraindications: Increased sensitivity to any components of the product.

Warnings: There are no special precautions need when TRAVELPHAGE TM is used.

The medicine should be stored in the original package, in the sight protected from light.

Interaction with other products: The incompatibility of the medicine with other pharmaceuticals is not ascertained. The preparation is possible to be used in complex treatment with other medicines, including antibacterial agents (antibiotics).

Pregnancy and lactation: The product is allowed to be used during pregnancy and lactation.

Effects on ability to drive and use other machines: TRAVELPHAGE TM does not affect the ability to drive a car and/or use other machines.

Dosage and administration: One of the most important provisoes of the effective treatment with this product is to detect the sensitivity of microorganism to phage (to phages of medicine), beforehand. Product is more effective while using in the early stage of the disease.

TRAVELPHAGE TM should be taken orally on the first day of the disease with first revealing symptoms, in prior of 1 hour before a meal.

Treatment duration generally is 1 to 2 weeks. In case of need, it is possible to repeat the treatment course.

Recommended dosage schema of intestinal infections treatment is:

Age Oral Administration Frequency of Administration
From 3 to 8 years 1 capsule 3 times a day
8 years and above 2 capsules 3 times a day

Prevention of intestinal infections is:

In case of prevention need, the product is prescribed 3-4 times a week according to the recommended schema:

Age Oral Administration Frequency of Administration
From 3 to 8 years 1 capsule 1 time a day
8 years and above 2 capsules 1 time a day

In the environment of the high risk of disease development, caused by the following bacterias: Shigella, Salmonella, E.coli, Proteus, Staphylococcus, Pseudomonas, Enterococcus, and also in the epidemy development fear, the product is taken daily, one capsule per day. In such a case, the dosage and therapy duration increase is acceptable.

Overdose: No cases of overdose have been reported.

Side effects: The medicine is non-toxic; no side effects or harmful influence on the human body is observed after administration of TRAVELPHAGE TM.

Presentation: 10 capsules in a PVC/Aluminum blister. 2 blisters with patient information leaflet are packed in a carton box.

Storage and transportation: Store in a dry, protected from the light place, below 25˚C temperature.

Keep out of reach of the children!

Product distribution is allowed by any type of closed transport, where suitable temperature condition provision is possible, during the whole transportation period.

Shelf-life: Product is valid for 2 years, from manufacturing date, if proper storage conditions are obtained. Do not use the medicine after its expiration date.

Warning: If after visual inspection of the product any defects are seen, it is not recommended for use.

Release from the pharmacy: Without prescription